Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Hagerstown, MD
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Hollywood, MD
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Hollywood, MD
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Boston, MA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Watertown, MA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Watertown, MA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Chesterfield, MI
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Traverse City, MI
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Traverse City, MI
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Troy, MI
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Troy, MI
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Wyoming, MI
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Wyoming, MI
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Plymouth, MN
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Jackson, MS
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Jackson, MS
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Florissant, MO
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Florissant, MO
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Saint Louis, MO
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Bozeman, MT
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Bozeman, MT
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Las Vegas, NV
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Las Vegas, NV
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Brooklyn, NY
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Endwell, NY
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Endwell, NY
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Great Neck, NY
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Asheville, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Charlotte, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Concord, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Concord, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Davidson, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Davidson, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Fayetteville, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Greensboro, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
High Point, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Raleigh, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Wilmington, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Winston Salem, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Winston Salem, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Winston Salem, NC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Fargo, ND
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Fargo, ND
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Cincinnati, OH
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Cincinnati, OH
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Columbus, OH
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Mentor, OH
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Mentor, OH
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Sylvania, OH
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Sylvania, OH
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Oklahoma City, OK
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Levittown, PA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Levittown, PA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Washington, PA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Washington, PA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Anderson, SC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Greer, SC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Simpsonville, SC
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Dakota Dunes, SD
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Dakota Dunes, SD
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Bristol, TN
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Bristol, TN
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Chattanooga, TN
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Knoxville, TN
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Nashville, TN
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Beaumont, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Beaumont, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Dallas, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
El Paso, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
El Paso, TX
Click here to add this to my saved trials